Fennec Pharmaceuticals to Report Second Quarter 2023 Financial Results on August 3, 2023 - Fennec Pharmaceuticals (NASDAQ:FENC)

RESEARCH TRIANGLE PARK, N.C., July 31, 2023 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ:FENC, TSX:FRX), a commercial stage specialty pharmaceutical company, today announced that the Company will release its

Related Keywords

Oregon ,United States ,Robert Andrade ,Lindsay Rocco ,Science University ,Fennec Pharmaceuticals ,Fennec Pharmaceuticals Inc ,Elixir Health Public Relations ,Oregon Health ,Webcast Detail ,Event Calendar ,European Commission Marketing Authorization ,Orphan Drug Exclusivity ,Pediatric Use Marketing Authorization ,